292 related articles for article (PubMed ID: 34051043)
1. Poor response at restaging MRI and high incomplete resection rates of locally advanced mucinous rectal cancer after chemoradiation therapy.
Koëter T; Stijns RCH; van Koeverden S; Hugen N; van der Heijden JAG; Nederend J; van Zwam PH; Nagtegaal ID; Verheij M; Rutten HJT; de Wilt JHW
Colorectal Dis; 2021 Sep; 23(9):2341-2347. PubMed ID: 34051043
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of progression-free survival for locally advanced rectal cancer by MRI after neoadjuvant chemoradiotherapy and total mesorectal excision].
Zhang JX; Yang Z; Fan P; Zhang JJ; Xin L; Hou LN; Du XS; Yang XT
Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):121-126. PubMed ID: 29502372
[No Abstract] [Full Text] [Related]
3. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic staging with magnetic resonance imaging after preoperative chemoradiotherapy in rectal cancer: pooled analysis of KROG 10-01 and 11-02.
Lee JH; Jang HS; Kim JG; Lee MA; Kim DY; Kim TH; Oh JH; Park SC; Kim SY; Baek JY; Park HC; Kim HC; Nam TK; Chie EK; Jung JH; Oh ST
Radiother Oncol; 2014 Oct; 113(1):18-23. PubMed ID: 25245559
[TBL] [Abstract][Full Text] [Related]
5. Mucinous Degeneration on MRI After Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: Frequency and Association With Clinical Outcomes.
Miranda J; Pinto PVA; Kinochita F; Garcia CM; El Homsi M; Vilela de Oliveira C; Pandini RV; Nahas CSR; Nahas SC; Gollub MJ; Horvat N
AJR Am J Roentgenol; 2023 Aug; 221(2):206-216. PubMed ID: 36919880
[No Abstract] [Full Text] [Related]
6. Rectal cancer: mucinous carcinoma on magnetic resonance imaging indicates poor response to neoadjuvant chemoradiation.
Oberholzer K; Menig M; Kreft A; Schneider A; Junginger T; Heintz A; Kreitner KF; Hötker AM; Hansen T; Düber C; Schmidberger H
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):842-8. PubMed ID: 21236593
[TBL] [Abstract][Full Text] [Related]
7. A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trial.
Battersby NJ; Dattani M; Rao S; Cunningham D; Tait D; Adams R; Moran BJ; Khakoo S; Tekkis P; Rasheed S; Mirnezami A; Quirke P; West NP; Nagtegaal I; Chong I; Sadanandam A; Valeri N; Thomas K; Frost M; Brown G
Trials; 2017 Aug; 18(1):394. PubMed ID: 28851403
[TBL] [Abstract][Full Text] [Related]
8. Impact of PET/CT for Restaging Patients With Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation.
Sorenson E; Lambreton F; Yu JQ; Li T; Denlinger CS; Meyer JE; Sigurdson ER; Farma JM
J Surg Res; 2019 Nov; 243():242-248. PubMed ID: 31229791
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiotherapy improves local recurrence free survival in locally advanced rectal cancer.
Tural D; Ozturk M; Selcukbiricik F; Yildiz O; Elicin O; Turna H; Guney S; Ozguroglu M
J BUON; 2013; 18(2):385-90. PubMed ID: 23818350
[TBL] [Abstract][Full Text] [Related]
10. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
[TBL] [Abstract][Full Text] [Related]
11. MAGNETIC RESONANCE IMAGING TO EVALUATE NEOADJUVANT THERAPY EFFECTS ON RECTAL CARCINOMA.
Sofić A; Vukobrat-Bijedić Z; Husić-Selimović A; Šehović N; Buija D; Eminagić D; Banjin M; Đuran A
Acta Clin Croat; 2015 Sep; 54(3):303-8. PubMed ID: 26666099
[TBL] [Abstract][Full Text] [Related]
12. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
[TBL] [Abstract][Full Text] [Related]
13. Predictive Significance of Mucinous Histology on Pathologic Complete Response Rate Following Capecitabine-Based Neoadjuvant Chemoradiation in Rectal Cancer: a Comparative Study.
Hosseini S; Nguyen N; Mohammadianpanah M; Mirzaei S; Bananzadeh AM
J Gastrointest Cancer; 2019 Dec; 50(4):716-722. PubMed ID: 29984382
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging following neoadjuvant chemoradiation and transanal endoscopic microsurgery for rectal cancer.
São Julião GP; Ortega CD; Vailati BB; Habr-Gama A; Fernandez LM; Gama-Rodrigues J; Araujo SE; Perez RO
Colorectal Dis; 2017 Jun; 19(6):O196-O203. PubMed ID: 28436197
[TBL] [Abstract][Full Text] [Related]
15. Cross-Sectional Study on MRI Restaging After Chemoradiotherapy and Interval to Surgery in Rectal Cancer: Influence on Short- and Long-Term Outcomes.
Detering R; Borstlap WAA; Broeders L; Hermus L; Marijnen CAM; Beets-Tan RGH; Bemelman WA; van Westreenen HL; Tanis PJ;
Ann Surg Oncol; 2019 Feb; 26(2):437-448. PubMed ID: 30547330
[TBL] [Abstract][Full Text] [Related]
16. Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients.
Lee SF; Chiang CL; Lee FAS; Wong YW; Poon CM; Wong FCS; Tung SY
J Formos Med Assoc; 2018 Sep; 117(9):825-832. PubMed ID: 29100742
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and clinical significance of cellular and acellular mucin in patients with locally advanced mucinous rectal cancer who underwent preoperative chemoradiotherapy followed by radical surgery.
Kang CM; Lim SB; Hong SM; Yu CS; Hong YS; Kim TW; Park JH; Kim JH; Kim JC
Colorectal Dis; 2016 Jan; 18(1):O10-6. PubMed ID: 26530997
[TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance imaging defined mucinous rectal carcinoma is an independent imaging biomarker for poor prognosis and poor response to preoperative chemoradiotherapy.
Yu SK; Chand M; Tait DM; Brown G
Eur J Cancer; 2014 Mar; 50(5):920-7. PubMed ID: 24440086
[TBL] [Abstract][Full Text] [Related]
19. The impact of circumferential tumour location on the clinical outcome of rectal cancer patients managed with neoadjuvant chemoradiotherapy followed by total mesorectal excision.
Wang X; Chen G; Zhang Y; Ghareeb WM; Yu Q; Zhu H; Lu X; Huang Y; Huang S; Hou D; Chi P
Eur J Surg Oncol; 2020 Jun; 46(6):1118-1123. PubMed ID: 32113887
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic performance of magnetic resonance to assess treatment response after neoadjuvant therapy in patients with locally advanced rectal cancer.
Nahas SC; Nahas CSR; Cama GM; de Azambuja RL; Horvat N; Marques CFS; Menezes MR; Junior UR; Cecconello I
Abdom Radiol (NY); 2019 Nov; 44(11):3632-3640. PubMed ID: 30663025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
